Loading
CP
Cotinga Pharmaceuticals Inc. (formerly, Critical Outcome Technologies Inc.) Stock: price and insider trades · Canada
Cotinga Pharmaceuticals Inc. (formerly, Critical Outcome Technologies Inc.): what insiders have been doing
Every trade that managers of Cotinga Pharmaceuticals Inc. (formerly, Critical Outcome Technologies Inc.) disclose to SEDI is tracked on this page. Nothing new has been filed by managers of Cotinga Pharmaceuticals Inc. (formerly, Critical Outcome Technologies Inc.) in twelve months, the latest record being from 29 January 2019.
The full history, which starts in 2018, counts 3 purchases against 1 sale.
These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Insider Decl.
11
Thresholds
n/a
Buy Volume
€386,153
3 ops. · all time
Sell Volume
€8,523
1 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 29 January 2019
Declarations11 total
241,000 shares@ CA$2.4189.7% of flowCommon SharesTSXSEDI:3307131
Canonical exit: 29 Apr 2019 (T+90)
239,000 shares@ CA$0.05574.0% of flowCommon SharesTSXSEDI:3287845
24,000 shares@ CA$0.1317.8% of flowCommon SharesTSXSEDI:3240078
Canonical exit: 20 Dec 2018 (T+90)
10,000 shares@ CA$0.1448.2% of flowCommon SharesTSXSEDI:3240077
Canonical exit: 20 Dec 2018 (T+90)
76,300 shares@ CA$0.38100.0% of flowCommon SharesTSXSEDI:3178648
40,100 shares@ CA$0.38100.0% of flowCommon SharesTSXSEDI:3178656
13,200 shares@ CA$0.38100.0% of flowCommon SharesTSXSEDI:3178665
131,500 shares@ CA$0.387.6% of flowCommon SharesTSXSEDI:3178640
20,000 shares@ CA$0.38100.0% of flowCommon SharesTSXSEDI:3178660
62,800 shares@ CA$0.38100.0% of flowCommon SharesTSXSEDI:3178653
Common SharesTSXSEDI:3178647
11 of 11 declarations
About Cotinga Pharmaceuticals Inc. (formerly, Critical Outcome Technologies Inc.)
Cotinga Pharmaceuticals Inc., formerly known as Critical Outcome Technologies Inc., is a biopharmaceutical company focused on developing innovative treatments for serious diseases. It is listed on the Toronto Stock Exchange (XTSE).
